Chemoinformaics analysis of Regholarrhenine F
| Molecular Weight | 388.64 | nRot | 4 |
| Heavy Atom Molecular Weight | 344.288 | nRig | 20 |
| Exact Molecular Weight | 388.345 | nRing | 4 |
| Solubility: LogS | -3.696 | nHRing | 0 |
| Solubility: LogP | 4.312 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 2 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 72 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 28 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 44 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 25 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 74.0909 |
| nHD | 1 | BPOL | 47.5611 |
| QED | 0.722 |
| Synth | 4.658 |
| Natural Product Likeliness | 2.48 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.002 |
| HIA | 0.008 |
| CACO-2 | -5.235 |
| MDCK | 0.00000425 |
| BBB | 0.277 |
| PPB | 0.634337 |
| VDSS | 1.544 |
| FU | 0.464019 |
| CYP1A2-inh | 0.021 |
| CYP1A2-sub | 0.142 |
| CYP2c19-inh | 0.015 |
| CYP2c19-sub | 0.992 |
| CYP2c9-inh | 0.02 |
| CYP2c9-sub | 0.053 |
| CYP2d6-inh | 0.838 |
| CYP2d6-sub | 0.941 |
| CYP3a4-inh | 0.075 |
| CYP3a4-sub | 0.911 |
| CL | 18.386 |
| T12 | 0.033 |
| hERG | 0.051 |
| Ames | 0.013 |
| ROA | 0.125 |
| SkinSen | 0.015 |
| Carcinogencity | 0.344 |
| EI | 0.007 |
| Respiratory | 0.983 |
| NR-Aromatase | 0.002 |
| Antiviral | No |
| Prediction | 0.638667 |